Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
30
2026

How 2026 Code Changes Shifted SRT from Sensus Healthcare to a Standard Treatment Option

For nearly a century, surgical excision and Mohs surgery have been the gold standard for treating patients who have non-melanoma skin cancer (NMSC) and keloid disease. The surgery works extremely well – with cure rates…

August
24
2018

Making Sense of the Link Between Skin Color and Skin Cancer

While those with lighter skin tones are generally the most at risk for skin cancer, anyone with any skin color can get skin cancer. Unfortunately, many patients are under the impression that those with darker…

July
20
2018

Is Your Blood Pressure Medicine Increasing Your Risk of Skin Cancer?

A recent study published in the Journal of American Dermatology has suggested a link between a commonly prescribed blood pressure medicine and skin cancer. Researchers at the University of Southern Denmark found that one of…

April
28
2018

See and Treat with the SRT-100 Vision for Skin Cancer Treatment

Superficial Radio Therapy is the premier choice for physicians and patients when it comes to skin cancer treatment options. With the SRT-100 Vision for Skin Cancer Treatment, physicians and patients alike, are privileged to witness…

April
03
2018

Educating Your Patients on Keloid Removal Success Rates

A keloid is a cutaneous mass that characteristically develops following a dermal injury. The keloid has beset dermatologists and cosmetic surgeons for decades, in view of both its pathological evolution and therapeutic challenges. Classically described…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry